These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2942457)

  • 21. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.
    Locke TJ; Odom NJ; Tapson JS; Freeman R; McGregor CG
    J Heart Transplant; 1987; 6(2):120-2. PubMed ID: 3040944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
    Alenius S; Laurent U; Oberg B
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential of phosphonoformate for the treatment of herpex simplex labialis.
    Oxford J
    J Antimicrob Chemother; 1980 Nov; 6(6):694-5. PubMed ID: 6449499
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in the vaginal cytology of the guinea pig induced by herpes simplex virus.
    Lucia HL; Mayo DR; Hsiung GD
    Acta Cytol; 1983; 27(3):365-70. PubMed ID: 6223477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical interferon cream for the treatment of herpes genitalis: a double-blind controlled trial.
    Batcheler LM; Bonham DG; Collins R; Liddell HS
    Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):239-41. PubMed ID: 3028362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous herpes simplex virus infections.
    Arbesfeld DM; Thomas I
    Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes.
    Douglas JM; Judson FN; Levin MJ; Bosso JA; Spruance SL; Johnston JM; Corey L; McMillan JA; Weiner LB; Frank JA
    Antimicrob Agents Chemother; 1986 Mar; 29(3):464-7. PubMed ID: 3521487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian males. A placebo-controlled, double-blind study.
    Syed TA; Cheema KM; Kahlon BM; Kahlon RC; Khayyami M; Kahlon AM; Kahlon MM
    Dermatology; 1995; 191(1):32-5. PubMed ID: 8589479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
    N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
    Schacker TW; Conant M; Thoming C; Stanczak T; Wang Z; Smith M
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3243-8. PubMed ID: 12234851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genivir (DIP-253) 1% cream versus placebo cream in the treatment of recurrent genital herpes: a double-blind study.
    Lassus A; Dahlgren A; Linnavuori K
    Int J STD AIDS; 1990 Jan; 1(1):18-20. PubMed ID: 2099194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical heparin for recurrent genital herpes simplex virus infections. A proposed model for subsequent therapeutic trials.
    Grossman JH; Thonnard-Neumann E
    J Reprod Med; 1985 Sep; 30(9):675-6. PubMed ID: 3903156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
    Ganly PS; Arthur C; Goldman JM; Schulenburg WE
    Postgrad Med J; 1988 May; 64(751):389-91. PubMed ID: 2849092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
    McCarty JR; Jarratt MT
    J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
    Gaub J; Pedersen C; Poulsen AG; Mathiesen LR; Ulrich K; Lindhardt BO; Faber V; Gerstoft J; Hofmann B; Lernestedt JO
    AIDS; 1987 May; 1(1):27-33. PubMed ID: 2962590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
    Sherker AH; Hirota K; Omata M; Okuda K
    Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminating herpes simplex infection: primary lesions in urinary bladder and successful treatment with forscarnet sodium.
    Blohmé I; Ahlmén J; Jeansson S; Ranch T; Brynger H
    Transplant Proc; 1984 Dec; 16(6):1672-4. PubMed ID: 6239431
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.